Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Instituto do Cancer do Estado de São Paulo
Fundación de investigación HM
National Institutes of Health Clinical Center (CC)
Centre Oscar Lambret
Stanford University
Hoffmann-La Roche
University of Alberta
Jonsson Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Mayo Clinic
ITM Solucin GmbH
Perspective Therapeutics
Jonsson Comprehensive Cancer Center
PharmaMar
Grupo Espanol de Tumores Neuroendocrinos
National Cancer Institute (NCI)
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Peking Union Medical College Hospital
Hoffmann-La Roche
Radio Isotope Therapy of America
Excel Diagnostics and Nuclear Oncology Center
University of Iowa
University of Alberta
University of Iowa
University of Iowa
University of Iowa
M.D. Anderson Cancer Center
University of Iowa
University of California, San Francisco
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
University of Warmia and Mazury
Molecular Insight Pharmaceuticals, Inc.
University of California, San Francisco
University of Cincinnati
Stanford University
Molecular Insight Pharmaceuticals, Inc.
University of Iowa
University College, London
Molecular Insight Pharmaceuticals, Inc.